Reports and Analyses

A Study of the Qualitative Impact of Non-Medical Switching |    Abstract

A Study of the Qualitative Impact of Non-Medical Switching | Abstract

Co-pay Accumulator Adjustment Programs: What can Policymakers do to Protect Patients?

Co-pay Accumulator Adjustment Programs: What can Policymakers do to Protect Patients?

Co-pay Accumulator Adjustment Programs

Co-pay Accumulator Adjustment Programs

 
Protecting Access to Diabetes Care

Protecting Access to Diabetes Care

 
Cost-Motivated Treatment Changes: Implications for Non-Medical Switching

Cost-Motivated Treatment Changes: Implications for Non-Medical Switching

 
Decision Impact: Understanding Formulary Exclusions

Decision Impact: Understanding Formulary Exclusions

National Diabetes Statistics Report, 2017

National Diabetes Statistics Report, 2017

 
Achieving Insulin Access and Innovation

Achieving Insulin Access and Innovation

 
AACE/ACE Position Statement on Patient Access to Necessary and Appropriate Medical Care

AACE/ACE Position Statement on Patient Access to Necessary and Appropriate Medical Care

Cost-Motivated Treatment Changes & Non-Medical Switching: Commercial Health Plans Analysis

Cost-Motivated Treatment Changes & Non-Medical Switching: Commercial Health Plans Analysis

 
Emphasize Shared Decision-Making Between Physicians and Patients to Improve Diabetes Outcomes

Emphasize Shared Decision-Making Between Physicians and Patients to Improve Diabetes Outcomes

 Podcast

In this episode, Frank Lavernia, MD, explains how insulin pricing has evolved, why it’s becoming unaffordable and what that means for diabetes patients.  He also describes a new trend in pharmacies’ distribution of insulin pens.


Videos


Infographics

 
 
Non-Medical Switching

Non-Medical Switching

Non-Medical Switching

Non-Medical Switching

The Staggering Costs of Diabetes

The Staggering Costs of Diabetes

A Non-Medical Switching Story: Diabetes

A Non-Medical Switching Story: Diabetes